JENNIFER KNAPP: Open Payments
NPI 1720497837 · SIMPSONVILLE, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$280 in 14 payments from 8 companies in 2025. Trend: 2023 $134 · 2024 $405 · 2025 $280
Food & beverage: $280
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 3 | $84 |
| Novo Nordisk Inc | 3 | $54 |
| Amgen Inc. | 2 | $43 |
| Lilly USA, LLC | 2 | $39 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $16 |
| Merck Sharp & Dohme LLC | 1 | $15 |
| PFIZER INC. | 1 | $15 |
| SHIELD THERAPEUTICS INC | 1 | $14 |
Products named: UBRELVY, OTEZLA, ZEPBOUND, Wegovy, Ozempic, Rybelsus, CAPLYTA, M-M-R II.
Industry payments across SC — which companies pay providers there.
